Atherectomy Devices - Global Strategic Business Report

The global market for Atherectomy Devices was estimated at US$889.1 Million in 2025 and is projected to reach US$1.5 Billion by 2032, growing at a CAGR of 7.8% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Atherectomy Devices Market - Key Trends and Drivers Summarized

Why Are Atherectomy Devices Crucial in Cardiovascular Interventions?

Atherectomy devices have become essential tools in the management of peripheral and coronary artery disease, conditions characterized by the accumulation of atherosclerotic plaque within the arteries. These devices are used to remove or debulk plaque from arterial walls, thereby restoring blood flow and reducing the risk of serious complications such as heart attacks, strokes, and limb amputations. Unlike traditional angioplasty, which primarily compresses plaque against the artery walls, atherectomy physically removes the plaque, offering a more definitive solution in certain cases. The importance of atherectomy devices is underscored by their use in treating complex lesions that are difficult to manage with standard angioplasty and stenting techniques. As cardiovascular disease continues to be a leading cause of morbidity and mortality worldwide, the role of atherectomy devices in enhancing patient outcomes and expanding treatment options remains critical.

How Are Technological Advancements Improving the Efficacy of Atherectomy Devices?

Technological advancements have significantly improved the efficacy and safety of atherectomy devices, driving innovation in the field of interventional cardiology. Modern atherectomy devices are designed to be more precise, minimizing the risk of damage to the arterial walls while effectively removing calcified and fibrotic plaque. The development of directional atherectomy, which allows for targeted plaque removal, has enabled physicians to treat more complex and calcified lesions with greater accuracy. Additionally, advancements in rotational and orbital atherectomy devices have enhanced their ability to navigate tortuous vessels and treat lesions that were previously considered inoperable. These devices now often come equipped with imaging capabilities, such as intravascular ultrasound (IVUS) or optical coherence tomography (OCT), which provide real-time visualization of the artery during the procedure. This integration of imaging technology allows for more informed decision-making and precise plaque removal, reducing the likelihood of complications and improving long-term outcomes for patients.

What Market Trends Are Influencing the Adoption of Atherectomy Devices?

Several market trends are influencing the adoption of atherectomy devices, reflecting the broader shifts in cardiovascular care and treatment strategies. The increasing prevalence of peripheral artery disease (PAD) and coronary artery disease (CAD), driven by factors such as aging populations, rising obesity rates, and the global increase in diabetes, is leading to greater demand for advanced interventional tools like atherectomy devices. Additionally, there is a growing trend towards minimally invasive procedures, as both patients and healthcare providers seek to reduce recovery times, hospital stays, and overall healthcare costs. Atherectomy devices, with their ability to effectively treat complex lesions through a minimally invasive approach, align well with this trend. The expanding body of clinical evidence supporting the efficacy of atherectomy in improving long-term patient outcomes is also driving adoption. Furthermore, the development of next-generation devices that offer enhanced safety profiles and the ability to treat a wider range of lesion types is expanding the indications for atherectomy and making it a more attractive option in cardiovascular interventions.

What Factors Are Driving the Growth of the Atherectomy Devices Market?

The growth in the atherectomy devices market is driven by several factors that are reshaping the landscape of cardiovascular care. A primary driver is the increasing incidence of cardiovascular diseases, particularly peripheral artery disease (PAD) and coronary artery disease (CAD), which are major contributors to morbidity and mortality globally. Technological advancements in device design and imaging integration are also propelling market growth by improving the safety and efficacy of atherectomy procedures. The trend towards minimally invasive surgical techniques is further boosting demand, as atherectomy offers an effective option for patients with complex or heavily calcified lesions that are not well-suited to traditional angioplasty or stenting. Additionally, the expansion of healthcare infrastructure in emerging markets, coupled with increasing awareness of advanced interventional cardiology techniques, is contributing to the growth of the atherectomy devices market. As these factors continue to evolve, the market for atherectomy devices is expected to experience sustained growth, driven by innovation, expanding indications, and the increasing global burden of cardiovascular diseases.

Report Scope

The report analyzes the Atherectomy Devices market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:

• Segments: Product (Directional Atherectomy Devices, Orbital Atherectomy Devices, Photo-Ablative Atherectomy Devices, Rotational Atherectomy Devices, Support Devices); Application (Peripheral Vascular, Cardiovascular, Neurovascular); End-Use (Hospitals & Surgical Centers, Ambulatory Care Centers, Research Laboratories & Academic Institutes)
• Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Directional Atherectomy Type segment, which is expected to reach US$639.8 Million by 2032 with a CAGR of a 9.4%. The Rotational Atherectomy Type segment is also set to grow at 8.5% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $275.0 Million in 2025, and China, forecasted to grow at an impressive 12.5% CAGR to reach $387.9 Million by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Atherectomy Devices Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Atherectomy Devices Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Atherectomy Devices Market expected to evolve by 2032?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2032?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Abbott Laboratories, Avinger, Inc., B. Braun SE, Biomerics, LLC, Biotronik SE & Co. KG and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Atherectomy Devices market report include:

• Abbott Laboratories
• Avinger, Inc.
• B. Braun SE
• Biomerics, LLC
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Medtronic Plc
• Minnetronix Medical, Inc.
• Terumo Corporation

Domain Expert Insights

This market report incorporates insights from domain experts across enterprise, industry, academia, and government sectors. These insights are consolidated from multilingual multimedia sources, including text, voice, and image-based content, to provide comprehensive market intelligence and strategic perspectives. As part of this research study, the publisher tracks and analyzes insights from 18,113 domain experts. Clients may request access to the network of experts monitored for this report, along with the online expert insights tracker.